Monitor RVPH price action after March 9, 2026 to see if the reverse split achieves sustained >$1.00 bid price for 10 consecutive days required for Nasdaq compliance. Watch for potential liquidity deterioration and whether the company can maintain compliance through March 27, 2026 deadline.
Price Chart
Executive Summary
Reviva Pharmaceuticals Holdings is implementing a 1-for-20 reverse stock split effective March 9, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement after receiving a delisting notice. The reverse split aims to increase the stock price but may reduce liquidity and does not address underlying business fundamentals.
Key Facts
- Company is executing a 1-for-20 reverse stock split effective March 9, 2026
- Reverse split is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement
- Company received Nasdaq delisting notice on May 13, 2025 for failing to maintain $1.00 minimum bid price
- Nasdaq granted an exception period through March 27, 2026 to demonstrate compliance
- No fractional shares will be issued; fractional entitlements will be rounded up to the nearest whole share
- CUSIP number will change to 76152G 209 while trading symbol RVPH remains unchanged
Financial Impact
The reverse stock split will reduce the number of outstanding shares by 95% (1:20 ratio) but will not change the company's $29M market capitalization or equity structure. No financial costs or dilution impact are disclosed.
Risk Factors
- Failure to maintain $1.00+ bid price for 10 consecutive days by March 27, 2026 could result in Nasdaq delisting
- Reduced share count may decrease liquidity and increase volatility
- Reverse split does not improve underlying business fundamentals or revenue prospects
- Market perception of reverse splits as negative signal could pressure share price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-006991 |
| Document: 0001437749-26-006991-index-headers.html | 0001437749-26-006991 |
| Document: 0001437749-26-006991-index.html | 0001437749-26-006991 |
| Document: 0001437749-26-006991.txt | 0001437749-26-006991 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | Press Release | $0.3521 $0.3521 | · 0.00% | ▲ +1.75% | $0.5000 (+42.01%) |
Jul 10, 2026 12w ago | 25-NSE | $0.6200 $0.4775 | ▲ +22.98% | ▲ +25.40% | $0.5000 (+19.35%) |
May 13, 2026 20w ago | Press Release | $0.3900 $0.6839 | ▼ −75.36% | ▼ −76.22% | $0.5000 (−28.21%) |
May 13, 2026 20w ago | 8-K | $0.3521 $0.7600 | ▼ −115.85% | ▼ −116.46% | $0.5000 (−42.01%) |
Apr 15, 2026 24w ago | 8-K | $0.8900 $0.8000 | ▼ −10.11% | ▼ −16.16% | $0.5000 (−43.82%) |
Mar 30, 2026 26w ago | Press Release | $0.6600 $0.8800 | ▲ +33.33% | ▲ +20.74% | $0.5000 (−24.24%) |
Mar 19, 2026 28w ago | Press Release | $0.8300 $0.8500 | ▼ −2.41% | ▲ +5.21% | $0.5000 (+39.76%) |
Mar 18, 2026 28w ago | Press Release | $0.8300 $0.8500 | ▲ +2.41% | ▼ −5.21% | $0.5000 (−39.76%) |
Mar 5, 2026 30w ago | 8-K | $4.20 $0.7200 | ▼ −82.86% | ▼ −79.07% | $0.5000 (−88.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access